EDS: Clients who used a story slugged BC-CNS-Theranos Arizona that moved Wednesday, Dec. 16, under a PHOENIX dateline, are asked to use the following correction. An updated version of the story has been posted here. The error occurred in the 21st paragraph of the original article.
PHOENIX – A Dec. 16 Cronkite News story about blood-testing company Theranos incorrectly stated the scope of Food and Drug Administration action at another lab, at-home DNA-testing service 23andMe. The FDA ordered 23andMe to stop marketing its DNA test for analysis of risk factors for disease until the test could be evaluated, but the company’s other tests were not affected. The company’s products have since been returned to the market.